Barrow, Hanley, Mewhinney & Strauss’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-143,538
| Closed | -$6.86M | – | 352 |
|
|
2018
Q4 | $6.86M | Hold |
143,538
| – | – | 0.01% | 152 |
|
|
2018
Q3 | $7.21M | Sell |
143,538
-44,622
| -24% | -$2.24M | 0.01% | 163 |
|
|
2018
Q2 | $9.48M | Hold |
188,160
| – | – | 0.02% | 159 |
|
|
2018
Q1 | $9.19M | Hold |
188,160
| – | – | 0.01% | 155 |
|
|
2017
Q4 | $8.34M | Hold |
188,160
| – | – | 0.01% | 159 |
|
|
2017
Q3 | $9.55M | Hold |
188,160
| – | – | 0.01% | 158 |
|
|
2017
Q2 | $10.1M | Hold |
188,160
| – | – | 0.02% | 158 |
|
|
2017
Q1 | $9.92M | Hold |
188,160
| – | – | 0.01% | 157 |
|
|
2016
Q4 | $9.06M | Hold |
188,160
| – | – | 0.01% | 159 |
|
|
2016
Q3 | $10.1M | Sell |
188,160
-13,280
| -7% | -$716K | 0.02% | 157 |
|
|
2016
Q2 | $10.9M | Hold |
201,440
| – | – | 0.02% | 156 |
|
|
2016
Q1 | $10.2M | Buy |
201,440
+2,240
| +1% | +$114K | 0.02% | 148 |
|
|
2015
Q4 | $10M | Hold |
199,200
| – | – | 0.02% | 150 |
|
|
2015
Q3 | $9.57M | Sell |
199,200
-2,640
| -1% | -$127K | 0.01% | 149 |
|
|
2015
Q2 | $10.5M | Sell |
201,840
-14,880
| -7% | -$775K | 0.01% | 151 |
|
|
2015
Q1 | $12.5M | Hold |
216,720
| – | – | 0.02% | 156 |
|
|
2014
Q4 | $11.6M | Hold |
216,720
| – | – | 0.02% | 155 |
|
|
2014
Q3 | $12.5M | Hold |
216,720
| – | – | 0.02% | 158 |
|
|
2014
Q2 | $14.5M | Buy |
+216,720
| New | +$14.5M | 0.02% | 160 |
|